Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Proton Therapy × Head & Neck × Clear all

Phase

Phase NA 2 Phase 2 2 Phase 3 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 3 Head & Neck 1 Endocrine 1 CNS 1

Conditions

Oropharyngeal Neoplasms 1 Head and Neck Neoplasms 1

Interventions

pembrolizumab 71 Cisplatin 66 Cetuximab 46 Radiotherapy 40 Nivolumab 30 Radiotherapy, Intensity-Modulated 24 Docetaxel 22 Fluorouracil 21 Paclitaxel 19 Cyclophosphamide 19 Radiation 17 Gemcitabine 17 fludarabine 16 Carboplatin 16 durvalumab 14 Erlotinib Hydrochloride 14 atezolizumab 11 Magnetic Resonance Spectroscopy 11 fludarabine phosphate 9 Radiosurgery 9 Interleukin-2 9 Drug Therapy 9 budigalimab 8 Ipilimumab 8 Bortezomib 8 Biopsy 8 130-nm albumin-bound paclitaxel 8 tremelimumab 7 Specimen Handling 7 Pemetrexed 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06446713 2025-04-03

PIRATES

University Medical Center Groningen

Phase 1 Recruiting

Head and Neck Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡